Chinese scientists have found abiotic organic compounds in the ocean crust, shedding light on deep-sea carbon cycles and life ...

By exploiting the genetic variation in cancer cells, an already approved cancer drug demonstrated enhanced effects against ...

The functional films industry size is anticipated to expand its roots at a steady CAGR of 7.2% between 2023 and 2033. The ...

Outpace Bio, a cell therapy company using unrivaled AI-powered protein design to program immune cells with improved efficacy against solid tumors, announced today that it will present new data on its ...

In the fourth quarter of 2024, we expect to announce updated data from the VTP-300 program in ongoing clinical trials in chronic hepatitis B at AASLD – The Liver Meeting® 2024 scheduled from November ...

By exploiting the genetic variation in cancer cells, an already approved cancer drug demonstrated enhanced effects against cancer cells in specific patient groups.

By exploiting the genetic variation in cancer cells, an already approved cancer drug demonstrated enhanced effects against cancer cells in specific patient groups, according to a new study. The ...

In a paper published in Science Bulletin, multi-omics analyses comprising of lipidomics (439 lipids), sterolomics (22 ...

Matica Biotechnology (Matica Bio), a leading contract development and manufacturing organization (CDMO) for viral vectors, ...

Sphere Fluidics, a leading provider of innovative droplet-based microfluidics solutions for functional profiling of single ...

Outpace Bio will share updated preclinical efficacy results for OPB ... In vivo tumor re-implant and CAR T serial transfer studies further demonstrate long-lived functional persistence, anti-tumor ...